Japan

Amgen migraine advocacy project wins trophy at the Healthcare Asia Pharma Awards

Amgen migraine advocacy project wins trophy at the Healthcare Asia Pharma Awards

An online seminar gathered specialists, influencers, journalists, patients, and caregivers toend the stigma surrounding migraine.

NDR Medical expands with new Japan office

It marked the fourth location in the Asia Pacific.

Japanese teenager first to use hospital's 'confidential birth'

The system was the only one of its kind in the country.

Slowing economy to affect Japan’s pharmaceuticals spending: Fitch

It also said that the annual medicine price review will affect medicine’s market growth trajectory. 

Disease awareness boosts Japan’s KRAS oncogene test market

Nucleic acid amplification tests dominate the market.

Drug approvals boost Japanese migraine treatment online

Some players have been highly active in digital channels of various countries.

Japan’s intracranial stents market rises amidst hospital backlogs

The device is mainly used for patients with intracranial atherosclerotic disease (ICAD).

Rising elderly population boosts Japan's TAVR market 

In Japan, TAVR is indicated for patients with severe aortic valve stenosis.

BMS wins Marketing & Communications Initiative of the Year - Japan at Healthcare Asia Pharma Awards

It relaunched the Hemapedia website as an innovative, digital platform under an omni-channel strategy. 

Japan's liver cancer surveillance program hailed as world's best

The country established the programme for early detection of HCC in the 1980s.

State support boosts Japan's assisted reproductive tech market

The country has the largest market for such devices used for addressing infertility.

Japan's neurology devices market to rebound in five years

The country accounted for a third of the market across Asia Pacific.

Japan's melanoma market urged to ramp up social media activity

Companies were advised to include content providing emotional support for patients.

Digital support for type 2 diabetes patients remain limited

This presents opportunities for digital marketing of T2D therapeutics.

Japan signs deals for vaccine preorders four times the population

The move was lauded as local vaccines remain in Phase II stage.

Fujitsu, Tokyo Shinagawa to develop AI-supported diagnosis of COVID-19 pneumonia

The system is expected to deliver early detection of cases, even when the probablity of infection is low.

COVID-19 dampens Japan's pharma market

Reduced healthcare spending will affect multinationals' capabilities to launch new products.